Literature DB >> 18057259

Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation.

Min-Jung Kim1, Sun-Young Hwang, Tadaatsu Imaizumi, Joo-Yeon Yoo.   

Abstract

RIG-I senses intracellular virus-specific nucleic acid structures and initiates an antiviral response that induces interferon (IFN) production, which, in turn, activates the transcription of RIG-I to increase RIG-I protein levels. Upon intracellular poly(I:C) stimulation, however, the levels of RIG-I protein did not correlate with the expression patterns of RIG-I transcripts. When the ISG15 conjugation system was overexpressed, ISG15 was conjugated to RIG-I and cellular levels of the unconjugated form of RIG-I decreased. The ISGylation of RIG-I reduced levels of both basal and virus-induced IFN promoter activity. Levels of unconjugated RIG-I also decreased when 26S proteasome activity was blocked by treatment with MG132, ALLN, or Lactacystin. In the presence of MG132, ISG15 conjugation to RIG-I increased, and hence, the unconjugated form of RIG-I was reduced. In Ube1L(-/-) cells, which lack the ability to conjugate ISG15, basal levels of both RIG-I protein and transcripts were increased compared to those in wild-type cells. As a result, enhanced production of ISGs and enhanced IFN promoter activity in Ube1L(-/-) cells were observed, and the phenotype was restored to that of wild-type cells by the overexpression of Ube1L. Based on these results, we propose a novel negative feedback loop which adjusts the strength of the RIG-I-mediated antiviral response and IFN production through the regulation of RIG-I protein by IFN-induced ISG15 conjugation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18057259      PMCID: PMC2224411          DOI: 10.1128/JVI.01650-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Cell type-specific involvement of RIG-I in antiviral response.

Authors:  Hiroki Kato; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Satoshi Uematsu; Kosuke Matsui; Tohru Tsujimura; Kiyoshi Takeda; Takashi Fujita; Osamu Takeuchi; Shizuo Akira
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

2.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

Review 3.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

Authors:  Chen Zhao; Carilee Denison; Jon M Huibregtse; Steven Gygi; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

5.  The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter.

Authors:  J Andrejeva; K S Childs; D F Young; T S Carlos; N Stock; S Goodbourn; R E Randall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

Review 6.  TLR3 in antiviral immunity: key player or bystander?

Authors:  Martina Schröder; Andrew G Bowie
Journal:  Trends Immunol       Date:  2005-09       Impact factor: 16.687

7.  ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus.

Authors:  Anna Osiak; Olaf Utermöhlen; Sandra Niendorf; Ivan Horak; Klaus-Peter Knobeloch
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

8.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

9.  Standardization of a duplex RT-PCR for the detection of Influenza A and Newcastle disease viruses in migratory birds.

Authors:  Paula Beatriz Munhoz Soares; Cristiane Demétrio; Luiz Sanfilippo; Adelia Hiroko Nagamori Kawanoto; Liana Brentano; Edison Luiz Durigon
Journal:  J Virol Methods       Date:  2005-02       Impact factor: 2.014

10.  The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins.

Authors:  K R Loeb; A L Haas
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

View more
  111 in total

1.  Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells.

Authors:  Daniel Klimmeck; Jenny Hansson; Simon Raffel; Sergey Y Vakhrushev; Andreas Trumpp; Jeroen Krijgsveld
Journal:  Mol Cell Proteomics       Date:  2012-03-27       Impact factor: 5.911

2.  Cell signaling. Anchors away for ubiquitin chains.

Authors:  Kislay Parvatiyar; Edward W Harhaj
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

3.  Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.

Authors:  Zhiguo Sun; Hongwei Ren; Yan Liu; Jessica L Teeling; Jun Gu
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

4.  A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.

Authors:  Suzanne Paz; Myriam Vilasco; Steven J Werden; Meztli Arguello; Deshanthe Joseph-Pillai; Tiejun Zhao; Thi Lien-Anh Nguyen; Qiang Sun; Eliane F Meurs; Rongtuan Lin; John Hiscott
Journal:  Cell Res       Date:  2011-01-04       Impact factor: 25.617

5.  Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 1 Interacts with a Member of the Interferon-Stimulated Gene 15 Pathway.

Authors:  Sarah R Jacobs; Charles M Stopford; John A West; Christopher L Bennett; Louise Giffin; Blossom Damania
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

6.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

7.  ISG15 is counteracted by vaccinia virus E3 protein and controls the proinflammatory response against viral infection.

Authors:  Benedito Eduardo-Correia; Carles Martínez-Romero; Adolfo García-Sastre; Susana Guerra
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 8.  Emerging roles for immunomodulatory functions of free ISG15.

Authors:  Jessica A Campbell; Deborah J Lenschow
Journal:  J Interferon Cytokine Res       Date:  2013-09-06       Impact factor: 2.607

Review 9.  Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity.

Authors:  Paola M Barral; Devanand Sarkar; Zao-zhong Su; Glen N Barber; Rob DeSalle; Vincent R Racaniello; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2009-07-15       Impact factor: 12.310

10.  USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I.

Authors:  Lijuan Wang; Wei Zhao; Meng Zhang; Peng Wang; Kai Zhao; Xueying Zhao; Shangru Yang; Chengjiang Gao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.